December 10th & 11th, 2026
15th edition
MARSEILLE, FR

Comparing 2 biotech companies’ business models and the way they get financed: Funding rounds vs. collaboration with pharma

Edition

Comparing 2 biotech companies’ business models and the way they get financed: Funding rounds vs. collaboration with pharma

What are the alternatives to the prevailing model of fundraising? Are there concrete growth opportunities relying only on licensing and collaboration deals? What are the criteria for fulfilling this alternative route? This session will draw on the experience of biotech companies embodying these different models.

Naheed Kurji

Co-founder, President & CEO
Cyclica

Natalia Novac

Senior Director Venture Science, Corporate Business Development
Eli Lilly and Company

Laurent Nguyen

Co-Founder & CEO
Accure Therapeutics

Sonia Hallen

Associate
LSP

Claire Skentelbery

Director General
EuropaBio
Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.